Document
type: Class

Journal of Drug Delivery Science and Technology
type: Document
type: Continuant
type: Collection
type: Entity
type: Information Content Entity
publication venue for: Tramadol extended-release porous silicon microcarriers: A kinetic, physicochemical and biological evaluation
type: Generically Dependent Continuant
type: Journal
type: Periodical
type: Thing

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

RDF description of Tramadol extended-release porous silicon microcarriers: A kinetic, physicochemical and biological evaluation - http://orbis.uaslp.mx/vivo/individual/scopus10072
rights: termsOfUse
date: 2026-08-25T01:05:02
publisher: vivo
type: Document

Article
type: Class

Information Content Entity
type: Class

Consejo Nacional de Ciencia y Tecnología, CONACYT: 335248, A1-S-31287
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Grant
type: Continuant
funding vehicle for: Tramadol extended-release porous silicon microcarriers: A kinetic, physicochemical and biological evaluation

Tramadol extended-release porous silicon microcarriers: A kinetic, physicochemical and biological evaluation
related by: authorship_69484
type: Entity
type: Information Content Entity
doi: 10.1016/j.jddst.2022.103132
artnum: 103132
type: Continuant
has publication venue: Journal of Drug Delivery Science and Technology
most specific type: Article
volume: 69
related by: authorship_69483
chemicalscas: silicon, 7440-21-3; tramadol, 27203-92-5, 36282-47-0
type: Thing
has funding vehicle: Consejo Nacional de Ciencia y Tecnología, CONACYT: 335248, A1-S-31287
related by: authorship_69485
crisid: 10073
freetext keyword: Commercial tramadol formulation; Drug release; Inflammation; Nociception; Porous silicon microparticles; Tramadol drug carrier; silicon; tramadol; animal experiment; animal model; antiinflammatory activity; antinociception; Article; carrageenan-induced paw edema; controlled study; drug delivery system; drug formulation; electrochemistry; evaluation study; Fourier transform infrared spectroscopy; in vivo study; inflammation; infrared spectroscopy; intestine fluid; kinetic parameters; male; mathematical model; nonhuman; pain threshold; parameters; particle size; pH; physical chemistry; pore size; porosity; rat; scanning electron microscopy; simulation; stomach juice; sustained drug release; synthesis; transmission electron microscopy; ultraviolet visible spectroscopy; zeta potential
related by: authorship_69482
type: Article
date time value: article date 10073
e iscopus: 2-s2.0-85123881930
estado: published
origen: scopus
manufactures: Sigma Aldrich, Mexico
type: Document
type: Generically Dependent Continuant
most specific type: Document
abstract: Thermally oxidized porous silicon particles have been widely studied as drug delivery systems for sustained release. In this work, TOPSip with different particle and pore dimensions were synthesized by electrochemical etching and used as microcarriers to sustain tramadol hydrochloride, a centrally acting opiate analgesic. The physicochemical and morphological properties of nanostructured TOPSip were fully characterized by scanning electron microscopy, transmission electron microscopy, Fourier transform infrared spectrometry and zeta potential. Modulation of the etching parameters allowed the control of the nano-pore size from 6 nm to 33 nm and particle size from 0.8 to 31 μm. Furthermore, TR loading capacity in TOPSip-OH was quantified by UV–Vis spectroscopy. TOPSip-OH with the smallest pore size exhibited a TR loading capacity of 10%25. In contrast, TOPSip-OH with the highest pore dimensions showed an increase in the loading capacity of tramadol up to 31%25. TR release was carefully studied in simulated gastric (pH 1.2) and intestinal fluids (pH 6.8). The released profiles demonstrated that microparticles with ∼6 nm pore size exhibited a sustained release up to 24 h with burst effect depending on pH. Release profiles of composites were compared with those obtained from a commercial extended-release tramadol formulation in both pH. It was observed that commercial composite released TR entirely after 1 h. TR cumulative release data were fitted using different mathematical models. Korsmeyer-Peppas fitted well for both simulated fluids. Through in vivo assessment, it was demonstrated that TR-loaded TOPSip sustains antinociceptive and anti-inflammatory effects compared to administration of tramadol at the same dose, which is a novel contribution of this work. © Elsevier B.V.